Suppr超能文献

在帕金森病动物模型中,发育期接触农药狄氏剂会改变多巴胺系统并增加神经毒性。

Developmental exposure to the pesticide dieldrin alters the dopamine system and increases neurotoxicity in an animal model of Parkinson's disease.

作者信息

Richardson Jason R, Caudle W Michael, Wang Minzheng, Dean E Danielle, Pennell Kurt D, Miller Gary W

机构信息

Center for Neurodegenerative Disease, School of Medicine, Emory University, Atlanta, Georgia 30322, USA.

出版信息

FASEB J. 2006 Aug;20(10):1695-7. doi: 10.1096/fj.06-5864fje. Epub 2006 Jun 29.

Abstract

Exposure to pesticides has been suggested to increase the risk of Parkinson's disease (PD), but the mechanisms responsible for this association are not clear. Here, we report that perinatal exposure of mice during gestation and lactation to low levels of dieldrin (0.3, 1, or 3 mg/kg every 3 days) alters dopaminergic neurochemistry in their offspring and exacerbates MPTP toxicity. At 12 wk of age, protein and mRNA levels of the dopamine transporter (DAT) and vesicular monoamine transporter 2 (VMAT2) were increased by perinatal dieldrin exposure in a dose-related manner. We then administered MPTP (2 x 10 mg/kg s.c) at 12 wk of age and observed a greater reduction of striatal dopamine in dieldrin-exposed offspring, which was associated with a greater DAT:VMAT2 ratio. Additionally, dieldrin exposure during development potentiated the increase in GFAP and alpha-synuclein levels induced by MPTP, indicating increased neurotoxicity. In all cases there were greater effects observed in the male offspring than the female, similar to that observed in human cases of PD. These data suggest that developmental exposure to dieldrin leads to persistent alterations of the developing dopaminergic system and that these alterations induce a "silent" state of dopamine dysfunction, thereby rendering dopamine neurons more vulnerable later in life.

摘要

接触杀虫剂被认为会增加患帕金森病(PD)的风险,但这种关联的机制尚不清楚。在此,我们报告,在妊娠和哺乳期围产期给小鼠低剂量狄氏剂(每3天0.3、1或3毫克/千克)会改变其后代的多巴胺能神经化学,并加剧MPTP毒性。在12周龄时,围产期狄氏剂暴露以剂量相关的方式增加了多巴胺转运体(DAT)和囊泡单胺转运体2(VMAT2)的蛋白质和mRNA水平。然后在12周龄时给小鼠腹腔注射MPTP(2×10毫克/千克),我们观察到狄氏剂暴露的后代纹状体多巴胺的减少幅度更大,这与更高的DAT:VMAT2比率相关。此外,发育期间狄氏剂暴露增强了MPTP诱导的GFAP和α-突触核蛋白水平的升高,表明神经毒性增加。在所有情况下,雄性后代比雌性后代受到的影响更大,这与人类PD病例中观察到的情况相似。这些数据表明,发育期间接触狄氏剂会导致发育中的多巴胺能系统持续改变,并且这些改变会引发多巴胺功能障碍的“沉默”状态,从而使多巴胺神经元在生命后期更容易受到影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验